Trial Profile
Effect of Vosaroxin versus cytarabine in patients with Acute Myeloid Leukaemia or Myelodysplastic syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Apr 2015
Price :
$35
*
At a glance
- Drugs Vosaroxin (Primary) ; Cytarabine
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 14 Apr 2015 New trial record